(Q36654598)

English

Optimizing treatment for elderly patients with acute promyelocytic leukemia: is it time to replace chemotherapy with all-trans retinoic acid and arsenic trioxide?

scientific article published on November 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

1 reference

Europe PubMed Central

Optimizing treatment for elderly patients with acute promyelocytic leukemia: is it time to replace chemotherapy with all-trans retinoic acid and arsenic trioxide? (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

acute promyelocytic leukemia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Hagop Kantarjian

2

object named as

Hagop Kantarjian

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Michael J. Keating

3

object named as

Michael J Keating

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Apostolia Maria Tsimberidou

1

object named as

Apostolia-Maria Tsimberidou

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

4

object named as

Elihu Estey

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 November 2006

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

47

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

2282-2288

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

The molecular basis of leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10428190600807178

21 January 2018

Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide

1 reference

https://api.crossref.org/works/10.1080%2F10428190600807178

21 January 2018

Arsenic trioxide therapy for relapsed or refractory Japanese patients with acute promyelocytic leukemia: need for careful electrocardiogram monitoring

1 reference

https://api.crossref.org/works/10.1080%2F10428190600807178

21 January 2018

Use of arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia: the M. D. Anderson experience

1 reference

https://api.crossref.org/works/10.1080%2F10428190600807178

21 January 2018

Experience with gemtuzumab ozogamycin ("mylotarg") and all-trans retinoic acid in untreated acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10428190600807178

21 January 2018

Extramedullary relapse in a patient with acute promyelocytic leukemia: successful treatment with arsenic trioxide, all-trans retinoic acid and gemtuzumab ozogamicin therapies

1 reference

https://api.crossref.org/works/10.1080%2F10428190600807178

21 January 2018

Potential curability of newly diagnosed acute promyelocytic leukemia without use of chemotherapy: the example of liposomal all-trans retinoic acid

1 reference

https://api.crossref.org/works/10.1080%2F10428190600807178

21 January 2018

Arsenic trioxide: new clinical experience with an old medication in hematologic malignancies

1 reference

https://api.crossref.org/works/10.1080%2F10428190600807178

21 January 2018

Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group

1 reference

https://api.crossref.org/works/10.1080%2F10428190600807178

21 January 2018

Treatment of elderly patients (> or =60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocols.

1 reference

https://api.crossref.org/works/10.1080%2F10428190600807178

21 January 2018

Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experience.

1 reference

https://api.crossref.org/works/10.1080%2F10428190600807178

21 January 2018

All-trans retinoic acid and anthracycline monochemotherapy for the treatment of elderly patients with acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10428190600807178

21 January 2018

Treatment of older adults with acute promyelocytic leukaemia

1 reference

https://api.crossref.org/works/10.1080%2F10428190600807178

21 January 2018

Use of all-trans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10428190600807178

21 January 2018

Reducing mortality associated with immediate treatment complications of adult leukemias

1 reference

https://api.crossref.org/works/10.1080%2F10428190600807178

21 January 2018

Identifiers

10.1080/10428190600807178

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

release_kyjoi4vy7be4lhsi4rclerfm6a

1 reference

https://api.fatcat.wiki/v0/release/kyjoi4vy7be4lhsi4rclerfm6a

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36654598&oldid=1836198787"